Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.
Imai
J
J
Division of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Ieiri
I
I
Mamiya
K
K
Miyahara
S
S
Furuumi
H
H
Nanba
E
E
Yamane
M
M
Fukumaki
Y
Y
Ninomiya
H
H
Tashiro
N
N
Otsubo
K
K
Higuchi
S
S
D000483:Alleles; D019943:Amino Acid Substitution; D001189:Aryl Hydrocarbon Hydroxylases; D065729:Cytochrome P-450 CYP2C9; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D005091:Exons / Q000235:genetics; D006801:Humans; D007564:Japan; D009154:Mutation; D010672:Phenytoin / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases / Q000235:genetics*
C001419:hydroxyphenytoin; D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System; D013250:Steroid Hydroxylases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D039181:Steroid 16-alpha-Hydroxylase